Skip to main content

QGEN · Qiagen N.V. · Documents

Track QGEN — free
$50.86 +0.03 (+0.06%) Play latest call Q2 2026 earnings call transcript
Market Cap
$10.49B
Shares
206.50M
Volume · Nov 5 4.17M Avg daily vol (3M) 3.67M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $2.09B up 5.7% 20-F filed Mar 20, 2026 Earnings call Q2 2026 earnings call Held Aug 6, 2026
2026
Oct 28
Tender offer SC TO-C
Tender offer

Crown NL Bidco B.V. plans a cash tender offer to acquire all issued ordinary shares of QIAGEN N.V. at €46.50 per share, pursuant to an October 21, 2026 Business Combination Agreement; the offer has not commenced.

Oct 23
Current report 6-K
Current report

QIAGEN N.V. agreed to a planned tender offer by Crown NL Bidco B.V. for all issued ordinary shares at €46.50 per share in cash, without interest, under an October 21, 2026 Business Combination Agreement; the offer had not yet commenced.

Read from the first part of this long document
Oct 22
Tender offer SC TO-C
Tender offer

Crown NL Bidco B.V. agreed to make an all-cash offer for all outstanding QIAGEN N.V. shares at €46.50 per share, unanimously supported by QIAGEN’s boards; closing is expected in mid-2027.

Read from the first part of this long document
Mar 20
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $2.09B ▲ 5.7% Net income $424.88M ▲ 408.3% Diluted EPS $1.94 ▲ 424.3%
2025
Mar 31
Annual report 20-F FY2024, ended Dec 31
Annual report for FY2024
Revenue $1.98B ▲ 0.7% Net income $83.59M ▼ 75.5% Diluted EPS $0.37 ▼ 75.0%
2024
Showing 1–50 of 160 documents
Key facts CIK 1015820 CUSIP N72482156 13F (30d) 132 filings 113 filers Visit website Investor relations